Hypha Discovery and Cypex announce a partnership to expand client access to drug metabolites

As a leading specialist CRO for drug metabolite provision, Hypha has formed a partnership with Cypex Limited, experts in the provision of a variety of recombinant xenobiotic metabolising enzymes, wherein Hypha will scale-up and purify metabolites made by Cypex enzymes. The partnership utilises the expert services Hypha Discovery already provides to pharmaceutical and agrochemical clients using its One Stop Metabolite Shop. The one-stop shop comprises a combination of both biological and chemical techniques so clients can quickly establish a method to identify and scale up production of any type of metabolite to support R&D needs. Expanding this toolbox to include additional xenobiotic-metabolising enzymes developed by Cypex, provides Hypha with even more options for synthesising and purifying metabolite standards for clients.

Read more here